Literature DB >> 8777722

Developmental defects of lymphoid cells in Jak3 kinase-deficient mice.

S Y Park1, K Saijo, T Takahashi, M Osawa, H Arase, N Hirayama, K Miyake, H Nakauchi, T Shirasawa, T Saito.   

Abstract

Jak3 is a tyrosine kinase mediating cytokine receptor signaling through the association with the common gamma chain of the cytokine receptors such as IL-2, IL-4, IL-7, IL-9, and IL-15. Unlike other members of the Jak family, the expression of Jak3 is highly restricted in hematopoietic cells. To elucidate in vivo function of Jak3, Jak3-deficient mice were generated by homologous recombination. Mice homozygous for Jak3 null mutation showed severe defects, specifically in lymphoid cells. B cell precursors in bone marrow, thymocytes, and both T and B cells in the spleen drastically decreased, although these defects were significantly recovered as aging occurred. Peripheral lymph nodes, NK cells, dendritic epidermal T cells, and intestinal intraepithelial gamma delta T cells were absent. Normal number of hematopoietic stem cells in bone marrow from Jak3-deficient mice and the similar capability to generate myeloid and erythroid colonies as wild-type mice indicated specific defects in lymphoid stem cells. Furthermore, the abnormal architecture of lymphoid organs suggested the involvement of Jak3 in the function of epithelial cells. T cells developed in the mutant mice did not respond to either IL-2, IL-4, or IL-7. These findings establish the crucial role of Jak3 in the development of lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8777722     DOI: 10.1016/1074-7613(95)90066-7

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  140 in total

1.  Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development.

Authors:  R Wen; D Wang; C McKay; K D Bunting; J C Marine; E F Vanin; G P Zambetti; S J Korsmeyer; J N Ihle; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 2.  Jaks and stats as therapeutic targets.

Authors:  J J O'Shea; R Visconti; T P Cheng; M Gadina
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 3.  Series introduction. JAK-STAT signaling in human disease.

Authors:  Christian W Schindler
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

4.  Differential requirement of the cytoplasmic subregions of gamma c chain in T cell development and function.

Authors:  S Tsujino; J P Di Santo; A Takaoka; T L McKernan; S Noguchi; C Taya; H Yonekawa; T Saito; T Taniguchi; H Fujii
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

5.  STAT5 is critical to maintain effector CD8+ T cell responses.

Authors:  Pulak Tripathi; Sema Kurtulus; Sara Wojciechowski; Allyson Sholl; Kasper Hoebe; Suzanne C Morris; Fred D Finkelman; H Leighton Grimes; David A Hildeman
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

6.  Interleukin 7 receptor-deficient mice lack gammadelta T cells.

Authors:  K Maki; S Sunaga; Y Komagata; Y Kodaira; A Mabuchi; H Karasuyama; K Yokomuro; J I Miyazaki; K Ikuta
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

7.  Targeting Janus tyrosine kinase 3 (JAK3) with an inhibitor induces secretion of TGF-β by CD4+ T cells.

Authors:  Marina Cetkovic-Cvrlje; Marin Olson; Ketaki Ghate
Journal:  Cell Mol Immunol       Date:  2012-06-25       Impact factor: 11.530

8.  Human lymphoid development in the absence of common γ-chain receptor signaling.

Authors:  Lisa A Kohn; Christopher S Seet; Jessica Scholes; Felicia Codrea; Rebecca Chan; Sania Zaidi-Merchant; Yuhua Zhu; Satiro De Oliveira; Neena Kapoor; Ami Shah; Hisham Abdel-Azim; Donald B Kohn; Gay M Crooks
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

9.  Human intestinal epithelial cell-derived interleukin (IL)-18, along with IL-2, IL-7 and IL-15, is a potent synergistic factor for the proliferation of intraepithelial lymphocytes.

Authors:  A Okazawa; T Kanai; K Nakamaru; T Sato; N Inoue; H Ogata; Y Iwao; M Ikeda; T Kawamura; S Makita; K Uraushihara; R Okamoto; M Yamazaki; M Kurimoto; H Ishii; M Watanabe; T Hibi
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 10.  Janus kinases in immune cell signaling.

Authors:  Kamran Ghoreschi; Arian Laurence; John J O'Shea
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.